Clinical Trials Logo

Filter by:
NCT ID: NCT04553198 Completed - Stroke Clinical Trials

Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery

BLT2
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Despite current walking rehabilitation strategies, the majority of stroke survivors are unable to walking independently in the community and remain at increased risk of falls. Backward treadmill training is a novel training approach used by elite athletes to enhance speed, agility, and balance; however, it is currently unknown how this exercise interacts with the central nervous system or if it could benefit stroke survivors with residual walking impairment. Knowledge gained from this study will likely lead to more effective walking rehabilitation strategies in stroke and related disorders.

NCT ID: NCT04553107 Completed - Polypharmacy Clinical Trials

Reducing Costs by Deprescribing Medications

Start date: December 9, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to implement a pharmacist-led deprescribing intervention for adults 65 and older taking 10 or more medications at University of Texas (UT) Physicians clinics and to assess the effect of the pharmacist intervention on the incidence of adverse drug reactions, emergency room visits, and hospitalizations as well as costs to the patient and to the healthcare system in adults 65 and older taking 10 or more medications treated at UT Physicians.

NCT ID: NCT04553068 Completed - Clinical trials for Sexually Transmitted Diseases

Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

EVOGUARD
Start date: October 15, 2020
Phase: Phase 3
Study type: Interventional

This study will evaluate whether EVO100 vaginal gel prevents the sexual transmission of CT and GC infection

NCT ID: NCT04553042 Completed - Healthy Clinical Trials

A Study of Seltorexant in Healthy Participants

Start date: September 14, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the bioequivalence of Test 1 and/or Test 2 seltorexant tablet formulations with respect to Reference seltorexant tablet formulation in healthy participants receiving a single dose under fasted conditions.

NCT ID: NCT04552912 Completed - Physical Activity Clinical Trials

Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia

Build Stamina
Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of an evidence-based tailored physical activity program adapted for adults with acute leukemia. Implementation-related process evaluation of the physical activity program will also be assessed.

NCT ID: NCT04552886 Completed - Glioblastoma Clinical Trials

Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma

Start date: October 11, 2021
Phase: Phase 1
Study type: Interventional

Effective treatments are desperately needed for glioblastoma (GBM) patients. This phase I clinical trial assesses the safety of a novel personalized dendritic-cell vaccine administered to GBM patients shortly after completing standard-of-care treatments. Secondary outcomes will evaluate patient progression-free survival and overall survival.

NCT ID: NCT04552860 Completed - Clinical trials for Musculoskeletal Pain

vEAET for Older Veterans With Chronic Musculoskeletal Pain Pilot

vEAET
Start date: August 15, 2020
Phase: N/A
Study type: Interventional

An uncontrolled pilot in which Veterans age 60-95 years with chronic musculoskeletal (MSK) pain will undergo Emotional Awareness and Expression Therapy (EAET) delivered over video teleconference (VTC; together vEAET). This study aims to obtain early implementation outcomes, as well as evaluate efficacy and estimated effect sizes.

NCT ID: NCT04552743 Completed - Multiple Myeloma Clinical Trials

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

Start date: October 5, 2020
Phase: Phase 2
Study type: Interventional

This study evaluates a new drug MGTA-145 in combination with plerixafor (Mozobil) to mobilize stem cells into the peripheral blood for collection by apheresis. The stem cells will be used for autologous stem cell transplant for treatment of multiple myeloma.

NCT ID: NCT04552730 Completed - Clinical trials for Neurotrophic Keratitis

Nerve Growth Factor for the Treatment of Cornea Disease

Start date: October 14, 2020
Phase:
Study type: Observational

To determine the efficacy and safety of nerve growth factor in the treatment of limbal stem cell deficiency (LSCD) associated with neurotrophic cornea.

NCT ID: NCT04552587 Completed - Clinical trials for Head and Neck Cancer

The HEART Study (Healthy Eating and Recovery Together)

Start date: December 4, 2020
Phase: N/A
Study type: Interventional

Head and neck cancer survivors and their primary caregivers (N=25 dyads) will be enrolled to pilot test a nutrition support system with a care planning clinic visit and a caregiver mobile App. Participants will be asked to complete baseline and 6-week follow-up surveys. The clinic session (offered in person or remotely) will include a needs assessment and a tailored care plan with information, educational materials and referrals about participants' symptoms, behaviors, social concerns and caregiving tasks. After the visit, the program will provide an App for caregivers with follow-up resources and mobile support for one month.